Condition
Relapsed Diffuse Large B Cell Lymphoma clinical trials and research
Research outlook What's coming for Diffuse large B-cell lymphoma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 4 Relapsed Diffuse Large B Cell Lymphoma clinical trials that are recruiting, at sites in 10 countries (most in United States (4), Canada (2), Australia (1)). By phase: Phase 2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 10Countries
Newest Relapsed Diffuse Large B Cell Lymphoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Epcoritamab treatment for certain types of lymphoma | Phase 2 | Philadelphia, Pennsylvania | Recruiting | Jun 13, 2024 |
| Long-term follow-up for patients treated with zamtocabtagene autoleucel | — | Gilbert, Arizona and 10 other locations | Recruiting | Nov 3, 2023 |
| Combination of DPX-Survivac and Pembrolizumab for Relapsed Lymphoma | Phase 2 | Fountain Valley, California and 49 other locations | Recruiting | Jun 10, 2021 |
| CAR-T cell therapy for relapsed or refractory DLBCL | Phase 2 | Birmingham, Alabama and 31 other locations | Recruiting | Mar 11, 2021 |
All recruiting trials (4)
-
Epcoritamab treatment for certain types of lymphoma
This study is testing if adding a new treatment called epcoritamab to CAR T cell therapy can help people with certain types of lymphoma who haven't fully responded to previous treatments.
-
Long-term follow-up for patients treated with zamtocabtagene autoleucel
This study follows patients who have received a specific CAR T-cell therapy for non-Hodgkin lymphoma to see how they do over time and if there are any long-term side effects.
-
Combination of DPX-Survivac and Pembrolizumab for Relapsed Lymphoma
This study is testing a new combination treatment of DPX-Survivac and pembrolizumab, with or without a low-dose chemotherapy drug, to see if it helps people with relapsed lymphoma feel better.
-
CAR-T cell therapy for relapsed or refractory DLBCL
This study is testing a new CAR-T cell therapy to see if it can help people with tough-to-treat diffuse large B cell lymphoma feel better after other treatments haven’t worked.
Related topics
Quick answers
How many Relapsed Diffuse Large B Cell Lymphoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 10 countries. The most sites are in United States (4 trials), Canada (2 trials), Australia (1 trial), France (1 trial), Hungary (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.